High-risk metastatic trophoblastic disease.

High risk occurs in these patients in two different forms--early and late. Early risks relate to the site and extent of tumors at the start of treatment; late risk is essentially that of drug resistance. Avoidance of drug resistance is the key objective. Central nervous system metastases and placental site trophoblastic tumor require special consideration.